Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
about
Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a reviewUltrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenograftsPreoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times.ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomasMutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicityThe anti-tumor effect of a polypeptide extracted from Tegillarca granosa Linnaeus on renal metastatic tumor OS-RC-2 cellsWhat do we know about IDH1/2 mutations so far, and how do we use it?Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers.Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkersBiomarkers classification and therapeutic decision-making for malignant gliomas.Accurate quantitation of Ki67-positive proliferating hepatocytes in rabbit liver by a multicolor immunohistochemical (IHC) approach analyzed with automated tissue and cell segmentation software.Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas.MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.Differential diagnosis of small cell glioblastoma and anaplastic oligodendroglioma: a case report of an elderly man.Detecting isocitrate dehydrogenase gene mutations in oligodendroglial tumors using diffusion tensor imaging metrics and their correlations with proliferation and microvascular density.Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours.Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.
P2860
Q26745588-AB20E1B4-C60A-4F2C-A66D-4DDFA83171B3Q28487464-FD106CF3-FE3A-4A66-AB69-D2BFE509A363Q30587443-3AD544F9-3BBB-46EC-A3BF-C5130A8DE5E8Q33784207-31D5D07F-D8F7-43F1-B7C4-F7A36167DE09Q34365966-4BCFEA72-38AA-485D-83CC-BB9A8F5F2ECFQ35992142-684038B9-0140-4389-975A-6B9B58207AC6Q36788229-481DC14B-B909-45E6-93DC-83B7B11E5DEFQ36873428-F217A507-7857-4BDB-A06D-A2A8C5A26BD0Q36873451-CDBB6D4F-524B-41D2-A999-8059FE80EF14Q39556985-CB86E126-0F66-4D3A-B051-2D21AFAAC4A8Q40060531-C58A449D-0AF1-46EE-B7A6-79C366CD1512Q40226917-67499834-5959-475E-AB2A-72C8B3647702Q41393365-65FA1D91-3A31-4C38-B67F-F86453BC7AADQ43184280-1D200A93-0B0D-41A1-8B33-C0E9FFCFCD2FQ45721936-7659AADF-48CB-4DA5-8ADD-A79B98F4246AQ47694150-ABCA7C5A-8D5A-46D5-B78D-C4C008E8B223Q48157881-C565F2BE-31C4-4979-B298-C9797698BE23Q48158056-5F22A664-FA70-4694-8672-E1DC6AA86091Q48331662-BE4A2AE3-2387-45E3-A057-25D0F7F30BF4Q48475366-D4C1B204-0EB3-4410-8242-F1A6B898C32CQ52148950-249BE07A-5325-454D-A9AE-0C507B36F2DAQ54123926-6D458CD4-C62B-4EA3-92C4-7B3F02D0F625Q55259357-0B7D3DCB-1A93-461F-899C-A2407AC30E88
P2860
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@en
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@nl
type
label
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@en
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@nl
prefLabel
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@en
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@nl
P2093
P2860
P50
P1433
P1476
Prognostic value of Ki67 index ...... t of Cancer Brain Tumor Group.
@en
P2093
Ahmed Idbaih
Ellen Gelpi
Harald Heinzl
Johan M Kros
Johannes A Hainfellner
Marc Sanson
Martin van den Bent
Romana Hoeftberger
Thierry Gorlia
P2860
P304
P356
10.1111/J.1365-2559.2011.04134.X
P577
2012-02-15T00:00:00Z